Qiang Zhang

23.2k total citations · 2 hit papers
402 papers, 19.2k citations indexed

About

Qiang Zhang is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Qiang Zhang has authored 402 papers receiving a total of 19.2k indexed citations (citations by other indexed papers that have themselves been cited), including 220 papers in Molecular Biology, 155 papers in Biomaterials and 102 papers in Biomedical Engineering. Recurrent topics in Qiang Zhang's work include Nanoparticle-Based Drug Delivery (152 papers), RNA Interference and Gene Delivery (116 papers) and Nanoplatforms for cancer theranostics (87 papers). Qiang Zhang is often cited by papers focused on Nanoparticle-Based Drug Delivery (152 papers), RNA Interference and Gene Delivery (116 papers) and Nanoplatforms for cancer theranostics (87 papers). Qiang Zhang collaborates with scholars based in China, United States and Japan. Qiang Zhang's co-authors include Xueqing Wang, Jiancheng Wang, Wenbing Dai, Hua Zhang, Bing He, Xuan Zhang, Wan-Liang Lü, Yiguang Wang, Binlong Chen and Jianping Zhou and has published in prestigious journals such as Science, Chemical Reviews and Journal of the American Chemical Society.

In The Last Decade

Qiang Zhang

398 papers receiving 18.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds

2013 1.0k citations Pingping Hou, Yanqin Li et al. Science profile →
A pyroptosis nanotuner for cancer therapy

2022 217 citations Binlong Chen, Yue Yan et al. Nature Nanotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qiang Zhang China	76	9.4k	7.5k	6.1k	2.8k	2.0k	402	19.2k
Jin Sun China	64	5.9k 0.6×	5.8k 0.8×	6.3k 1.0×	2.5k 0.9×	2.3k 1.1×	480	16.2k
Zhirong Zhang China	75	8.2k 0.9×	6.0k 0.8×	5.3k 0.9×	3.4k 1.2×	1.5k 0.8×	525	19.1k
S. Moein Moghimi United Kingdom	68	8.4k 0.9×	8.7k 1.1×	5.5k 0.9×	2.5k 0.9×	2.6k 1.3×	217	19.0k
Vladimir P. Torchilin United States	72	9.9k 1.1×	11.9k 1.6×	7.9k 1.3×	2.1k 0.7×	2.7k 1.3×	257	21.9k
Zhonggui He China	58	5.1k 0.5×	5.1k 0.7×	6.2k 1.0×	1.7k 0.6×	2.0k 1.0×	403	13.6k
Prashant Kesharwani India	76	8.0k 0.9×	6.6k 0.9×	5.5k 0.9×	3.3k 1.2×	2.4k 1.2×	568	20.2k
Vinod Labhasetwar United States	61	7.0k 0.8×	8.4k 1.1×	5.4k 0.9×	3.8k 1.3×	2.9k 1.4×	148	18.9k
Robert J. Lee United States	66	8.7k 0.9×	5.0k 0.7×	3.7k 0.6×	1.3k 0.5×	1.3k 0.6×	319	16.0k
Kwangmeyung Kim South Korea	88	10.0k 1.1×	11.2k 1.5×	12.1k 2.0×	2.3k 0.8×	4.8k 2.4×	381	25.8k
Andrew Z. Wang United States	60	5.4k 0.6×	6.8k 0.9×	7.3k 1.2×	987 0.4×	2.8k 1.4×	268	16.2k

Countries citing papers authored by Qiang Zhang

Since Specialization

Citations

This map shows the geographic impact of Qiang Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Zhang more than expected).

Fields of papers citing papers by Qiang Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiang Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Zhang. The network helps show where Qiang Zhang may publish in the future.

Co-authorship network of co-authors of Qiang Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Qiang Zhang. A scholar is included among the top collaborators of Qiang Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiang Zhang. Qiang Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Qiang, Xitong Yang, Xitong Yang, et al.. (2025). Spatiotemporal Circadian Oscillator Manipulation for Enhanced Ovarian Cancer Therapy Using a Versatile Nanoplatform. ACS Applied Materials & Interfaces. 17(24). 35023–35039. 1 indexed citations

Li, Yijia, Feiyang Deng, Yuxing Lin, et al.. (2024). A dual gene combination therapy approach by KRAS-G12V gene editing and SLC25A22 gene silencing for KRAS-mutant colorectal cancer. Nano Today. 56. 102291–102291. 3 indexed citations

Wang, Xing, Xing Wang, Feiyang Deng, et al.. (2024). Impact of Physiological Characteristics on Chylomicron Pathway-Mediated Absorption of Nanocrystals in the Pediatric Population. ACS Nano. 18(34). 23136–23153. 3 indexed citations

Sun, Yujie, Qiang Zhang, Shijie Cao, et al.. (2024). Tetrahydrocurcumin targets TRIP13 inhibiting the interaction of TRIP13/USP7/c-FLIP to mediate c-FLIP ubiquitination in triple-negative breast cancer. Journal of Advanced Research. 75. 591–605. 5 indexed citations

Yang, Liuqing, Di Wu, Hua Zhang, et al.. (2024). Engineering supramolecular peptide nanofibers for in vivo platelet-hitchhiking beyond ligand-receptor recognition. Science Advances. 10(43). eadq2072–eadq2072. 6 indexed citations

Gong, Lidong, Ridong Li, Xianling Ning, et al.. (2023). Discovery of a miniaturized PROTAC with potent activity and high selectivity. Bioorganic Chemistry. 136. 106556–106556. 15 indexed citations

Du, Yulin, Yifan Lyu, Jie Lin, et al.. (2023). Membrane-anchored DNA nanojunctions enable closer antigen-presenting cell–T-cell contact in elevated T-cell receptor triggering. Nature Nanotechnology. 18(7). 818–827. 65 indexed citations

Wu, Peiyao, Siyu Yao, Xing Wang, et al.. (2023). Oral administration of nanoformulated indoximod ameliorates ulcerative colitis by promoting mitochondrial function and mucosal healing. International Journal of Pharmaceutics. 637. 122813–122813. 14 indexed citations

Tu, Li, Zhongxiong Fan, Fukai Zhu, et al.. (2020). Self-recognizing and stimulus-responsive carrier-free metal-coordinated nanotheranostics for magnetic resonance/photoacoustic/fluorescence imaging-guided synergistic photo-chemotherapy. Journal of Materials Chemistry B. 8(26). 5667–5681. 36 indexed citations

10.

Yan, Yue, Binlong Chen, Zenghui Wang, et al.. (2020). Sequential Modulations of Tumor Vasculature and Stromal Barriers Augment the Active Targeting Efficacy of Antibody‐Modified Nanophotosensitizer in Desmoplastic Ovarian Carcinoma. Advanced Science. 8(3). 2002253–2002253. 31 indexed citations

11.

Peng, Youyi, Qiang Zhang, & William J. Welsh. (2020). Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management. Journal of Medicinal Chemistry. 64(1). 890–904. 12 indexed citations

12.

Li, Lihuang, Lihuang Li, Yanxiu Liu, et al.. (2019). Targeted Combination Therapy for Glioblastoma by Co-Delivery of Doxorubicin, YAP-siRNA and Gold Nanorods. SSRN Electronic Journal. 2 indexed citations

13.

Wang, Yaoqi, Xing Wang, Xing Wang, et al.. (2018). The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles. Journal of Controlled Release. 279. 136–146. 57 indexed citations

14.

Gao, Wei, Zhiqiang Lin, Bing He, et al.. (2017). The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT. Journal of Controlled Release. 261. 174–186. 15 indexed citations

15.

Wang, Ying, Yating Zhao, Yu Cui, et al.. (2017). Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers. Acta Biomaterialia. 65. 405–416. 54 indexed citations

16.

Yu, Chao, Bing He, Menghua Xiong, et al.. (2013). The effect of hydrophilic and hydrophobic structure of amphiphilic polymeric micelles on their transport in epithelial MDCK cells. Biomaterials. 34(26). 6284–6298. 39 indexed citations

17.

Hou, Pingping, Yanqin Li, Xu Zhang, et al.. (2013). Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds. Science. 341(6146). 651–654. 1014 indexed citations breakdown →

18.

Dai, Wenbing, Tingyuan Yang, Yiguang Wang, et al.. (2012). Peptide PHSCNK as an integrin α5β1 antagonist targets stealth liposomes to integrin-overexpressing melanoma. Nanomedicine Nanotechnology Biology and Medicine. 8(7). 1152–1161. 24 indexed citations

19.

Zhou, Changhua, Qiu Zhong, Lyndsay V. Rhodes, et al.. (2012). Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration. Breast Cancer Research. 14(2). R45–R45. 96 indexed citations

20.

Zhao, Ying, et al.. (2004). Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies. International Journal of Pharmaceutics. 281(1-2). 11–23. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact